Neurocrine Biosciences, Inc <NBIX.O>: Baird raises target price to $225 from $186
NBIX•Related News
Apple Inc <AAPL.O>: TD Cowen raises target price to $400 from $350
AAPL•
BOJ keeps rates steady, delivers hawkish signal as government props up yen
TLT•
TriNet Group Inc <TNET.N>: JPMorgan Raises Target Price to $50 From $45
TNET•
BOJ keeps rates steady, signals further rate hikes
TLT•
New York sues Kalshi, follows Coinbase and Gemini lawsuits
COIN•